BioSig Technologies Relocates Principal Executive Offices
Ticker: STEX · Form: 8-K · Filed: Sep 13, 2024 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Biosig Technologies, Inc. (STEX) |
| Form Type | 8-K |
| Filed Date | Sep 13, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001, $300,000, $0.4479 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-actions, executive-compensation, relocation
TL;DR
BioSig is moving its HQ to LA, check for exec comp changes.
AI Summary
BioSig Technologies, Inc. announced on September 11, 2024, a change in its principal executive offices to 12424 Wilshire Blvd, Ste 745, Los Angeles, California, 90025. This move from their previous Westport, CT address signifies a strategic shift for the company. The filing also indicates potential changes in officer or director compensation arrangements.
Why It Matters
A change in principal executive offices can signal strategic shifts, operational changes, or a move to a more favorable business environment for the company.
Risk Assessment
Risk Level: medium — Relocation of principal executive offices can sometimes precede significant strategic changes or financial restructuring, warranting closer observation.
Key Players & Entities
- BioSig Technologies, Inc. (company) — Registrant
- 12424 Wilshire Blvd, Ste 745 Los Angeles, California 90025 (location) — New Principal Executive Offices
- Westport, CT (location) — Previous Principal Executive Offices
FAQ
What is the new address for BioSig Technologies, Inc.'s principal executive offices?
The new address for BioSig Technologies, Inc.'s principal executive offices is 12424 Wilshire Blvd, Ste 745, Los Angeles, California, 90025.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on September 11, 2024.
What is the state of incorporation for BioSig Technologies, Inc.?
BioSig Technologies, Inc. is incorporated in Delaware.
What is the IRS Employer Identification Number for BioSig Technologies, Inc.?
The IRS Employer Identification Number for BioSig Technologies, Inc. is 26-4333375.
What items are being reported in this 8-K filing?
This 8-K filing reports on the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, and financial statements and exhibits.
Filing Stats: 1,129 words · 5 min read · ~4 pages · Grade level 16.2 · Accepted 2024-09-13 16:00:14
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share BSGM N/A Indicate by ch
- $300,000 — Executive's annual base salary shall be $300,000 ("Base Salary"), less applicable taxes
- $0.4479 — ptember 11, 2024 (the "Date of Grant"), $0.4479 per share (the "Options"), with 50% of
Filing Documents
- form8-k.htm (8-K) — 45KB
- ex10-1.htm (EX-10.1) — 89KB
- ex10-2.htm (EX-10.2) — 62KB
- ex10-3.htm (EX-10.3) — 93KB
- 0001493152-24-036190.txt ( ) — 508KB
- bsgm-20240911.xsd (EX-101.SCH) — 3KB
- bsgm-20240911_lab.xml (EX-101.LAB) — 33KB
- bsgm-20240911_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOSIG TECHNOLOGIES, INC. Date: September 13, 2024 By: /s/ Anthony Amato Name: Anthony Amato Title: Chief Executive Officer